Svar Life Science

February 18, 2025

Supporting smarter IBD monitoring

At Calpro, we are committed to improving the lives of those affected by Inflammatory Bowel Disease (IBD) while enhancing healthcare efficiency. Our focus on eHealth innovation allows us to streamline patient monitoring and provide reliable, cost-effective solutions for both patients and healthcare providers.

Managing IBD, including conditions like Crohn's disease and ulcerative colitis, can be challenging for both patients and healthcare providers. Frequent follow-up visits at the hospital can be burdensome and costly. However, with the CalproSmart® self-test, patients can monitor their condition from the comfort of their homes, significantly reducing the need for hospital visits and allowing for proactive disease management.

In our latest sponsored article on "Effektiv Velferd", we explore how self-testing is transforming IBD management - empowering patients with greater control over their condition and reducing the burden on healthcare systems.

🔗 Read the full article here (available in Norwegian):  Enkel og besparende selvtest for IBD

February 18, 2025

Supporting smarter IBD monitoring

At Calpro, we are committed to improving the lives of those affected by Inflammatory Bowel Disease (IBD) while enhancing healthcare efficiency. Our focus on eHealth innovation allows us to streamline patient monitoring and provide reliable, cost-effective solutions for both patients and healthcare providers.

Managing IBD, including conditions like Crohn's disease and ulcerative colitis, can be challenging for both patients and healthcare providers. Frequent follow-up visits at the hospital can be burdensome and costly. However, with the CalproSmart® self-test, patients can monitor their condition from the comfort of their homes, significantly reducing the need for hospital visits and allowing for proactive disease management.

In our latest sponsored article on "Effektiv Velferd", we explore how self-testing is transforming IBD management - empowering patients with greater control over their condition and reducing the burden on healthcare systems.

🔗 Read the full article here (available in Norwegian):  Enkel og besparende selvtest for IBD

E-HEALTH MONITORING AND BENEFITS

In recent years, E-Health has emerged as a powerful tool for helping patients remain in prolonged periods of remission. Unlike phone or online consultations, which only provide the treating physician with the patient's subjective observations, E-Health requires objective parameters for optimal distant monitoring. When implemented correctly, E-Health offers significant benefits for patients, physicians, hospitals, and society as a whole, drastically reducing the need for heavy medication, emergency admissions, and other expensive treatments.
Learn More about E-Health

BENEFITS OF SELF-TESTING

The adoption of self-testing in IBD care brings several key advantages:

  • CONVENIENCE & ACCESSIBILITY
    Patients can perform the test at home, saving time and reducing stress associated with hospital visits. 

  • COST-EFFECTIVENESS
    By minimizing the need for frequent in-person appointments, healthcare costs are reduced for both patients and providers. 

  • IMPROVED HEALTH OUTCOMES
    Regular monitoring enables early detection of changes in inflammation levels, allowing for timely intervention and better disease management.

CALPRO'S SUPPORT IN PATIENT EMPOWERMENT

Allowing patients to participate more fully in their disease management requires that they be equipped with monitoring tools that enable physicians to provide accurate follow-ups.

Want to know more about Calprotectin solutions for distant monitoring?
Take advantage of our expertise—contact us today!

 

 
Contact us!

 

References:

Ankersen DV et al., E-Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need. Intern Med J. 2021.

Burisch J et al., Telemonitoring and self-care in patients with IBD. In: RK Cross and AR Watson, eds. Telemanagement of Inflammatory Bowel Disease. Springer US; 2015.

De Jong MJ, et al., Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017.

De Jong MJ, et al., Costeffectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial. Clin Gastroenterol Hepatol. 2020.

Pang L, et al., Role of Telemedicinein Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Med Internet Res. 2022.